| Pharmaceutical active ingredients: |
| Dimercaprol |
| Available forms, composition and doses of British Anti-Lewisite: |
| N / A |
| British Anti-Lewisite medical category: |
| Human:AntidotesDetoxifying agents and drugs used in substance dependenceHeavy metal antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AB09 - Dimercaprol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Bristuron | Bendroflumethiazide | Unidentified Pharmaceutical Company |
| Britazepam | Diazepam | Unidentified Pharmaceutical Company |
| Britewood Q | Didecyl Dimethyl Ammonium Chloride | Unidentified Pharmaceutical Company |
| British Aluminum AF 260 | Aluminum Hydroxide | Unidentified Pharmaceutical Company |
| British AntiLewisite | Dimercaprol | Unidentified Pharmaceutical Company |
| British Gum | Icodextrin | Unidentified Pharmaceutical Company |
| Brittox | Bromoxynil | Unidentified Pharmaceutical Company |
| Broadside | Sodium Cacodylate | Unidentified Pharmaceutical Company |
| Brobamate | Meprobamate | Unidentified Pharmaceutical Company |
| Brocadisipal | Orphenadrine | Unidentified Pharmaceutical Company |